Health Condition 1: H251- Age-related nuclear cataract
Conditions
Interventions
Intervention1: Topical prednisolone and NSAID given sub-conjunctively: After performing phacoemulsification, patients shall receive intracameral antibiotic â?? moxifloxacin 500 microgram in 0.1 ml at
Sponsors
Aravind Eye Care System AECS
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 40 to 75 years 2. Patients undergoing topical phacoemulsification with monofocal foldable IOL implantation 3. Senile cataract 4. Axial length of 20.5 to 25mm 5. Staying within 100 kms from base hospital and willing for all follow up visits
Exclusion criteria
Exclusion criteria: 1. Age 2. Diabetes retinopathy 3. Advanced cataract (BCVA 3/60 or less) 4. NSIV, Posterior polar, subluxated , traumatic, complicated and developmental cataract 5. Pregnant and lactating women 6. Patients with mental illness 7. Non visualization of fundus 8. CDR of 0.7 & more 9. IOP of 21 & above 10. Known case of glaucoma diagnosed based on cup disc ratio, field defects, RNFL defects or raised IOP and on treatment for the same 11. Family history of glaucoma 12. H/O steroid responsiveness 13. On systemic steroids for asthma, rheumatoid arthritis or other illness or history of steroid use by any route in the prior 3 months 14. Corneal diseases 15. Prior incisional ocular surgery 16. Associated ocular comorbidity (ARMD, pseudo exfoliation, small pupil (5mm or less), floppy iris, corneal opacity, macular scar, epiretinal membrane, retinal detachment, uveitis, shallow anterior chamber) 17. Central macular thickness (CMT) >250 μ to rule out macular edema and pachychoroid 18. Subfoveal choroidal thickness (SFCT) >300 μ 19. Presence of pachyvessels on EDI (enhanced depth imaging) OCT 20. On alpha adrenergic blockers for benign prostatic hypertrophy 21. Any intraoperative complications (PCR , ZD , Nucleus drop, Vitreous loss, iris injury) 22. Axial length 25mm 23. Any intraoperative complications (PCR , ZD , Nucleus drop, Vitreous loss)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual outcome with refractive erros Timepoint: 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Macula thickness 2) Incidence of CME 3) On additional medication for raised IOP/ glaucoma due to steroids 4) On additional medication for break through iritisTimepoint: 12 months | — |
Countries
India
Contacts
Public ContactDr Haripriya Aravind
Aravind Eye Hospital
Outcome results
None listed